|
| 36056582 | The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancers. | Int J Cancer | 2023 |
| 37758816 | DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment. | NPJ Precis Oncol | 2023 |
| 37657418 | Biomarkers of aging for the identification and evaluation of longevity interventions. | Cell | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 36790339 | Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36810770 | HPV-induced host epigenetic reprogramming is lost upon progression to high-grade cervical intraepithelial neoplasia. | Int J Cancer | 2023 |
| 36533702 | The WID-EC test for the detection and risk prediction of endometrial cancer. | Int J Cancer | 2023 |
| 36368129 | Profiling the immune landscape in mucinous ovarian carcinoma. | Gynecol Oncol | 2023 |
| 36093582 | Assessing the risk of cervical neoplasia in the post-HPV vaccination era. | Int J Cancer | 2023 |
| 35105882 | The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples. | Nat Commun | 2022 |
| 35768851 | Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock. | Genome Biol | 2022 |
| 35701800 | Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women. | Genome Med | 2022 |
| 35854342 | Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women. | Genome Med | 2022 |
| 36414968 | DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WIDâ¿¢-qCIN test. | Clin Epigenetics | 2022 |
| 36001862 | A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets. | J Clin Oncol | 2022 |
| 36258199 | The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer. | Genome Med | 2022 |
| 35189945 | Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock. | Genome Biol | 2022 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 35105887 | The DNA methylome of cervical cells can predict the presence of ovarian cancer. | Nat Commun | 2022 |
| 34342797 | Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies. | Eur J Health Econ | 2021 |
| 33494753 | Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar. | Trials | 2021 |
| 34909561 | Human exposome assessment platform. | Environ Epidemiol | 2021 |
| 34432481 | Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II. | J Clin Oncol | 2021 |
| 32561125 | Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Gynecol Oncol | 2020 |
| 32071120 | A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies. | Cancer Prev Res (Phila) | 2020 |
| 33228781 | DNA methylation signatures to predict the cervicovaginal microbiome status. | Clin Epigenetics | 2020 |
| 33208479 | Prevention in the age of personal responsibility: epigenetic risk-predictive screening for female cancers as a case study. | J Med Ethics | 2020 |
| 33262282 | Targeting progesterone signaling prevents metastatic ovarian cancer. | Proc Natl Acad Sci U S A | 2020 |
| 32664613 | Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer-A Systematic Review. | Cancers (Basel) | 2020 |
| 32601456 | Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement. | Nat Rev Clin Oncol | 2020 |
| 32555420 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement. | Nat Rev Clin Oncol | 2020 |
| 32120796 | Non-Surgical Cancer Risk Reduction in <i>BRCA1</i> Mutation Carriers: Disabling the Remote Control. | Cancers (Basel) | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 31146730 | Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey. | BMC Public Health | 2019 |
| 29912290 | Accounting for differential variability in detecting differentially methylated regions. | Brief Bioinform | 2019 |
| 31300207 | Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. | Lancet Oncol | 2019 |
| 31239549 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. | Mod Pathol | 2019 |
| 31188874 | Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries. | PLoS One | 2019 |
| 28976616 | Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting. | Ultrasound Obstet Gynecol | 2018 |
| 30062862 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2018 |
| 30223261 | Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider. | Public Health Genomics | 2018 |
| 29978915 | Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways. | Int J Cancer | 2018 |
| 30593552 | What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. | BMJ Open | 2018 |
| 29693419 | A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix. | Epigenomics | 2018 |
| 29485132 | Epigenome-based cancer risk prediction: rationale, opportunities and challenges. | Nat Rev Clin Oncol | 2018 |
| 29735413 | DNA Methylation Patterns in Normal Tissue Correlate more Strongly with Breast Cancer Status than Copy-Number Variants. | EBioMedicine | 2018 |
| 29759571 | Prediction models for endometrial cancer for the general population or symptomatic women: A systematic review. | Crit Rev Oncol Hematol | 2018 |
| 29365106 | Psychosocial adversity and socioeconomic position during childhood and epigenetic age: analysis of two prospective cohort studies. | Hum Mol Genet | 2018 |
| 27825669 | Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: A single institution retrospective review. | Gynecol Oncol | 2017 |